Insect Cell Expression in Recombinant Protein Programs
Insect Cell Expression in Recombinant Protein Programs Insect cell expression returned to the news on October 29, 2026. Novavax announced a $125 million milestone after the fifth patient was dosed in Sanofi’s Phase 3 influenza-COVID-19 combination trial in Europe. Those deal terms are company-reported. Still, the antigen inside that study comes from insect cells, and … Continue reading Insect Cell Expression in Recombinant Protein Programs
